{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:21:37Z","timestamp":1788837697774,"version":"build-2803163510"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,15]]},"DOI":"10.7759\/cureus.90188","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:09:50Z","timestamp":1755302990000},"source":"Crossref","is-referenced-by-count":5,"title":["Epigenetic Dysregulation in Neurodegenerative Disease: Implications for Neuropathology and Therapy"],"prefix":"10.7759","author":[{"given":"Hussein","family":"Qasim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karis","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abu Shugaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2010.01010.x","article-title":"Basic mechanisms of neurodegeneration: a critical update","volume":"14","author":"Jellinger KA","year":"2010","unstructured":"Jellinger KA. Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med. 2010, 14:457-87. 10.1111\/j.1582-4934.2010.01010.x","journal-title":"J Cell Mol Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/563481","article-title":"Neurodegenerative diseases: multifactorial conformational diseases and their therapeutic interventions","volume":"2013","author":"Sheikh S","year":"2013","unstructured":"Sheikh S, Safia, Haque E, Mir SS. Neurodegenerative diseases: multifactorial conformational diseases and their therapeutic interventions. J Neurodegener Dis. 2013, 2013:563481. 10.1155\/2013\/563481","journal-title":"J Neurodegener Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01762-3","article-title":"Environmental exposures influence multigenerational epigenetic transmission","volume":"16","author":"Klibaner-Schiff E","year":"2024","unstructured":"Klibaner-Schiff E, Simonin EM, Akdis CA, et al.. Environmental exposures influence multigenerational epigenetic transmission. Clin Epigenetics. 2024, 16:145. 10.1186\/s13148-024-01762-3","journal-title":"Clin Epigenetics"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000323874","article-title":"Epigenetics: principles and practice","volume":"29","author":"Hamilton JP","year":"2011","unstructured":"Hamilton JP. Epigenetics: principles and practice. Dig Dis. 2011, 29:130-5. 10.1159\/000323874","journal-title":"Dig Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12292","article-title":"Epigenetic signature in neural plasticity: the journey so far and journey ahead","volume":"8","author":"Nayak M","year":"2022","unstructured":"Nayak M, Das D, Pradhan J, Ahmed RG, Laureano-Melo R, Dandapat J. Epigenetic signature in neural plasticity: the journey so far and journey ahead. Heliyon. 2022, 8:e12292. 10.1016\/j.heliyon.2022.e12292","journal-title":"Heliyon"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104929","article-title":"Reversing epigenetic dysregulation in neurodegenerative diseases: mechanistic and therapeutic considerations","volume":"26","author":"Olawade DB","year":"2025","unstructured":"Olawade DB, Rashad I, Egbon E, Teke J, Ovsepian SV, Boussios S. Reversing epigenetic dysregulation in neurodegenerative diseases: mechanistic and therapeutic considerations. Int J Mol Sci. 2025, 26:4929. 10.3390\/ijms26104929","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216320","article-title":"The role of non-coding RNAs in epigenetic dysregulation in glioblastoma development","volume":"24","author":"Isachesku E","year":"2023","unstructured":"Isachesku E, Braicu C, Pirlog R, et al.. The role of non-coding RNAs in epigenetic dysregulation in glioblastoma development. Int J Mol Sci. 2023, 24:16320. 10.3390\/ijms242216320","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/606172","article-title":"The aggregation of huntingtin and \u03b1-synuclein","volume":"2012","author":"Ch\u00e1nez-C\u00e1rdenas ME","year":"2012","unstructured":"Ch\u00e1nez-C\u00e1rdenas ME, V\u00e1zquez-Contreras E. The aggregation of huntingtin and \u03b1-synuclein. J Biophys. 2012, 2012:606172. 10.1155\/2012\/606172","journal-title":"J Biophys"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00058","article-title":"Epigenetic mechanisms in neurological and neurodegenerative diseases","volume":"9","author":"Landgrave-G\u00f3mez J","year":"2015","unstructured":"Landgrave-G\u00f3mez J, Mercado-G\u00f3mez O, Guevara-Guzm\u00e1n R. Epigenetic mechanisms in neurological and neurodegenerative diseases. Front Cell Neurosci. 2015, 9:58. 10.3389\/fncel.2015.00058","journal-title":"Front Cell Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2023.05.036","article-title":"How epigenetics impacts on human diseases","volume":"114","author":"Farsetti A","year":"2023","unstructured":"Farsetti A, Illi B, Gaetano C. How epigenetics impacts on human diseases. Eur J Intern Med. 2023, 114:15-22. 10.1016\/j.ejim.2023.05.036","journal-title":"Eur J Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073881","article-title":"An overview of the epigenetic modifications in the brain under normal and pathological conditions","volume":"25","author":"Lossi L","year":"2024","unstructured":"Lossi L, Castagna C, Merighi A. An overview of the epigenetic modifications in the brain under normal and pathological conditions. Int J Mol Sci. 2024, 25:3881. 10.3390\/ijms25073881","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore LD","year":"2013","unstructured":"Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013, 38:23-38. 10.1038\/npp.2012.112","journal-title":"Neuropsychopharmacology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2372","article-title":"5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary","volume":"19","author":"Khare T","year":"2012","unstructured":"Khare T, Pai S, Koncevicius K, et al.. 5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary. Nat Struct Mol Biol. 2012, 19:1037-43. 10.1038\/nsmb.2372","journal-title":"Nat Struct Mol Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2217\/epi.13.13","article-title":"The correlation between histone modifications and gene expression","volume":"5","author":"Dong X","year":"2013","unstructured":"Dong X, Weng Z. The correlation between histone modifications and gene expression. Epigenomics. 2013, 5:113-6. 10.2217\/epi.13.13","journal-title":"Epigenomics"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto E","year":"2014","unstructured":"Seto E, Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol. 2014, 6:a018713. 10.1101\/cshperspect.a018713","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2217\/imt.13.101","article-title":"Histone methyltransferase and histone methylation in inflammatory T-cell responses","volume":"5","author":"He S","year":"2013","unstructured":"He S, Tong Q, Bishop DK, Zhang Y. Histone methyltransferase and histone methylation in inflammatory T-cell responses. Immunotherapy. 2013, 5:989-1004. 10.2217\/imt.13.101","journal-title":"Immunotherapy"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/genes14020347","article-title":"Histone modifications in Alzheimer's disease","volume":"14","author":"Santana DA","year":"2023","unstructured":"Santana DA, Smith MA, Chen ES. Histone modifications in Alzheimer's disease. Genes (Basel). 2023, 14:347. 10.3390\/genes14020347","journal-title":"Genes (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-020-00717-x","article-title":"microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside","volume":"15","author":"Ratti M","year":"2020","unstructured":"Ratti M, Lampis A, Ghidini M, Salati M, Mirchev MB, Valeri N, Hahne JC. microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside. Target Oncol. 2020, 15:261-78. 10.1007\/s11523-020-00717-x","journal-title":"Target Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2012.08220.x","article-title":"MicroRNA-132 regulates recognition memory and synaptic plasticity in the perirhinal cortex","volume":"36","author":"Scott HL","year":"2012","unstructured":"Scott HL, Tamagnini F, Narduzzo KE, et al.. MicroRNA-132 regulates recognition memory and synaptic plasticity in the perirhinal cortex. Eur J Neurosci. 2012, 36:2941-8. 10.1111\/j.1460-9568.2012.08220.x","journal-title":"Eur J Neurosci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.929290","article-title":"Non-coding RNAs: the neuroinflammatory regulators in neurodegenerative diseases","volume":"13","author":"Jiang H","year":"2022","unstructured":"Jiang H, Zhang Y, Yue J, Shi Y, Xiao B, Xiao W, Luo Z. Non-coding RNAs: the neuroinflammatory regulators in neurodegenerative diseases. Front Neurol. 2022, 13:929290. 10.3389\/fneur.2022.929290","journal-title":"Front Neurol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13182888","article-title":"Cell-free miRNAs as non-invasive biomarkers in brain tumors","volume":"13","author":"Beylerli O","year":"2023","unstructured":"Beylerli O, Encarnacion Ramirez MJ, Shumadalova A, Ilyasova T, Zemlyanskiy M, Beilerli A, Montemurro N. Cell-free miRNAs as non-invasive biomarkers in brain tumors. Diagnostics (Basel). 2023, 13:2888. 10.3390\/diagnostics13182888","journal-title":"Diagnostics (Basel)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2023.0608","article-title":"Alzheimer's disease puzzle: delving into pathogenesis hypotheses","volume":"15","author":"Nasb M","year":"2024","unstructured":"Nasb M, Tao W, Chen N. Alzheimer's disease puzzle: delving into pathogenesis hypotheses. Aging Dis. 2024, 15:43-73. 10.14336\/AD.2023.0608","journal-title":"Aging Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/cells13080719","article-title":"Epigenetic changes in Alzheimer's disease: DNA methylation and histone modification","volume":"13","author":"De Plano LM","year":"2024","unstructured":"De Plano LM, Saitta A, Oddo S, Caccamo A. Epigenetic changes in Alzheimer's disease: DNA methylation and histone modification. Cells. 2024, 13:719. 10.3390\/cells13080719","journal-title":"Cells"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/eep\/dvx008","article-title":"DNA methylation alterations in Alzheimer's disease","volume":"3","author":"Yokoyama AS","year":"2017","unstructured":"Yokoyama AS, Rutledge JC, Medici V. DNA methylation alterations in Alzheimer's disease. Environ Epigenet. 2017, 3:dvx008. 10.1093\/eep\/dvx008","journal-title":"Environ Epigenet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci8090162","article-title":"A closer look into the role of protein tau in the identification of promising therapeutic targets for Alzheimer's disease","volume":"8","author":"Islam Khan R","year":"2018","unstructured":"Islam Khan R, Nirzhor SS, Rashid B. A closer look into the role of protein tau in the identification of promising therapeutic targets for Alzheimer's disease. Brain Sci. 2018, 8:162. 10.3390\/brainsci8090162","journal-title":"Brain Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2014.00397","article-title":"The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases","volume":"8","author":"Al-Mahdawi S","year":"2014","unstructured":"Al-Mahdawi S, Virmouni SA, Pook MA. The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases. Front Neurosci. 2014, 8:397. 10.3389\/fnins.2014.00397","journal-title":"Front Neurosci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2015.00347","article-title":"Epigenetic alterations in Alzheimer's disease","volume":"9","author":"Sanchez-Mut JV","year":"2015","unstructured":"Sanchez-Mut JV, Gr\u00e4ff J. Epigenetic alterations in Alzheimer's disease. Front Behav Neurosci. 2015, 9:347. 10.3389\/fnbeh.2015.00347","journal-title":"Front Behav Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-\u03b2 pathway in Alzheimer's disease","volume":"26","author":"Hampel H","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, et al.. The amyloid-\u03b2 pathway in Alzheimer's disease. Mol Psychiatry. 2021, 26:5481-503. 10.1038\/s41380-021-01249-0","journal-title":"Mol Psychiatry"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.911635","article-title":"Epigenetics in Alzheimer's disease","volume":"14","author":"Gao X","year":"2022","unstructured":"Gao X, Chen Q, Yao H, Tan J, Liu Z, Zhou Y, Zou Z. Epigenetics in Alzheimer's disease. Front Aging Neurosci. 2022, 14:911635. 10.3389\/fnagi.2022.911635","journal-title":"Front Aging Neurosci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01232-7","article-title":"Entorhinal cortex epigenome-wide association study highlights four novel loci showing differential methylation in Alzheimer's disease","volume":"15","author":"Sommerer Y","year":"2023","unstructured":"Sommerer Y, Dobricic V, Schilling M, et al.. Entorhinal cortex epigenome-wide association study highlights four novel loci showing differential methylation in Alzheimer's disease. Alzheimers Res Ther. 2023, 15:92. 10.1186\/s13195-023-01232-7","journal-title":"Alzheimers Res Ther"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2147\/DNND.S37341","article-title":"Epigenetic mechanisms in Alzheimer's disease","volume":"4","author":"Balazs R","year":"2014","unstructured":"Balazs R. Epigenetic mechanisms in Alzheimer's disease. Degener Neurol Neuromuscul Dis. 2014, 4:85-102. 10.2147\/DNND.S37341","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012081","article-title":"Epigenetic changes and chromatin reorganization in brain function: lessons from fear memory ensemble and Alzheimer's disease","volume":"23","author":"van Zundert B","year":"2022","unstructured":"van Zundert B, Montecino M. Epigenetic changes and chromatin reorganization in brain function: lessons from fear memory ensemble and Alzheimer's disease. Int J Mol Sci. 2022, 23:12081. 10.3390\/ijms232012081","journal-title":"Int J Mol Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X18666200128125641","article-title":"Alzheimer's disorder: epigenetic connection and associated risk factors","volume":"18","author":"Sharma VK","year":"2020","unstructured":"Sharma VK, Mehta V, Singh TG. Alzheimer's disorder: epigenetic connection and associated risk factors. Curr Neuropharmacol. 2020, 18:740-53. 10.2174\/1570159X18666200128125641","journal-title":"Curr Neuropharmacol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01078-9","article-title":"The role of histone modifications: from neurodevelopment to neurodiseases","volume":"7","author":"Park J","year":"2022","unstructured":"Park J, Lee K, Kim K, Yi SJ. The role of histone modifications: from neurodevelopment to neurodiseases. Signal Transduct Target Ther. 2022, 7:217. 10.1038\/s41392-022-01078-9","journal-title":"Signal Transduct Target Ther"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2019.110767","article-title":"Loss of NRF2 leads to impaired mitochondrial function, decreased synaptic density and exacerbated age-related cognitive deficits","volume":"131","author":"Zweig JA","year":"2020","unstructured":"Zweig JA, Caruso M, Brandes MS, Gray NE. Loss of NRF2 leads to impaired mitochondrial function, decreased synaptic density and exacerbated age-related cognitive deficits. Exp Gerontol. 2020, 131:110767. 10.1016\/j.exger.2019.110767","journal-title":"Exp Gerontol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang DM","year":"2009","unstructured":"Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT. Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci. 2009, 32:591-601. 10.1016\/j.tins.2009.06.002","journal-title":"Trends Neurosci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-024-00148-8","article-title":"Targeting neuronal epigenomes for brain rejuvenation","volume":"43","author":"Zocher S","year":"2024","unstructured":"Zocher S. Targeting neuronal epigenomes for brain rejuvenation. EMBO J. 2024, 43:3312-26. 10.1038\/s44318-024-00148-8","journal-title":"EMBO J"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2305-5839.2015.03.49","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease","volume":"3","author":"Wang WY","year":"2015","unstructured":"Wang WY, Tan MS, Yu JT, Tan L. Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease. Ann Transl Med. 2015, 3:136. 10.3978\/j.issn.2305-5839.2015.03.49","journal-title":"Ann Transl Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.908076","article-title":"Non-coding RNAs as novel regulators of neuroinflammation in Alzheimer's disease","volume":"13","author":"Liu Y","year":"2022","unstructured":"Liu Y, Cheng X, Li H, Hui S, Zhang Z, Xiao Y, Peng W. Non-coding RNAs as novel regulators of neuroinflammation in Alzheimer's disease. Front Immunol. 2022, 13:908076. 10.3389\/fimmu.2022.908076","journal-title":"Front Immunol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4081\/ejh.2019.3008","article-title":"miR-132 regulates the expression of synaptic proteins in APP\/PS1 transgenic mice through C1q","volume":"63","author":"Xu N","year":"2019","unstructured":"Xu N, Li AD, Ji LL, Ye Y, Wang ZY, Tong L. miR-132 regulates the expression of synaptic proteins in APP\/PS1 transgenic mice through C1q. Eur J Histochem. 2019, 63:10.4081\/ejh.2019.3008","journal-title":"Eur J Histochem"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen Y","year":"2023","unstructured":"Chen Y, Yu Y. Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation. J Neuroinflammation. 2023, 20:165. 10.1186\/s12974-023-02853-3","journal-title":"J Neuroinflammation"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00090","article-title":"microRNA-146a is a wide-reaching neuroinflammatory regulator and potential treatment target in neurological diseases","volume":"13","author":"Fan W","year":"2020","unstructured":"Fan W, Liang C, Ou M, Zou T, Sun F, Zhou H, Cui L. microRNA-146a is a wide-reaching neuroinflammatory regulator and potential treatment target in neurological diseases. Front Mol Neurosci. 2020, 13:90. 10.3389\/fnmol.2020.00090","journal-title":"Front Mol Neurosci"},{"key":"ref43","article-title":"Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer\u2019s disease","volume":"8","author":"Lei X","year":"2015","unstructured":"Lei X, Lei L, Zhang Z, Zhang Z, Cheng Y. Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer\u2019s disease. Int J Clin Exp Pathol. 2015, 8:1565-74.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14498","article-title":"Long non-coding RNAs as key regulators of neurodegenerative protein aggregation","volume":"21","author":"Xu Q","year":"2025","unstructured":"Xu Q, Liu D, Zhu LQ, Su Y, Huang HZ. Long non-coding RNAs as key regulators of neurodegenerative protein aggregation. Alzheimers Dement. 2025, 21:e14498. 10.1002\/alz.14498","journal-title":"Alzheimers Dement"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020276","article-title":"miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis","volume":"9","author":"Condrat CE","year":"2020","unstructured":"Condrat CE, Thompson DC, Barbu MG, et al.. miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis. Cells. 2020, 9:276. 10.3390\/cells9020276","journal-title":"Cells"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.152339799","article-title":"\u03b1-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease","volume":"99","author":"Lo Bianco C","year":"2002","unstructured":"Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P. \u03b1-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc Natl Acad Sci. 2002, 99:10813-8. 10.1073\/pnas.152339799","journal-title":"Proc Natl Acad Sci"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21277","article-title":"Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update","volume":"31","author":"Nuytemans K","year":"2010","unstructured":"Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat. 2010, 31:763-80. 10.1002\/humu.21277","journal-title":"Hum Mutat"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.6119-09.2010","article-title":"Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains","volume":"30","author":"Jowaed A","year":"2010","unstructured":"Jowaed A, Schmitt I, Kaut O, W\u00fcllner U. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains. J Neurosci. 2010, 30:6355-9. 10.1523\/JNEUROSCI.6119-09.2010","journal-title":"J Neurosci"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13012","article-title":"The epigenetic mechanisms involved in mitochondrial dysfunction: implication for Parkinson's disease","volume":"32","author":"Chen Z","year":"2022","unstructured":"Chen Z, Rasheed M, Deng Y. The epigenetic mechanisms involved in mitochondrial dysfunction: implication for Parkinson's disease. Brain Pathol. 2022, 32:e13012. 10.1111\/bpa.13012","journal-title":"Brain Pathol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C110.212589","article-title":"\u03b1-synuclein sequesters DNMT1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases","volume":"286","author":"Desplats P","year":"2011","unstructured":"Desplats P, Spencer B, Coffee E, et al.. \u03b1-synuclein sequesters DNMT1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. J Biol Chem. 2011, 286:9031-7. 10.1074\/jbc.C110.212589","journal-title":"J Biol Chem"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2015.10.021","article-title":"Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease","volume":"589","author":"Haddad D","year":"2015","unstructured":"Haddad D, Nakamura K. Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease. FEBS Lett. 2015, 589:3702-13. 10.1016\/j.febslet.2015.10.021","journal-title":"FEBS Lett"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04591-w","article-title":"The impact of the histone deacetylase inhibitor-sodium butyrate on complement-mediated synapse loss in a rat model of neonatal hypoxia-ischemia","volume":"62","author":"Ziabska K","year":"2025","unstructured":"Ziabska K, Gewartowska M, Frontczak-Baniewicz M, Sypecka J, Ziemka-Nalecz M. The impact of the histone deacetylase inhibitor-sodium butyrate on complement-mediated synapse loss in a rat model of neonatal hypoxia-ischemia. Mol Neurobiol. 2025, 62:5216-33. 10.1007\/s12035-024-04591-w","journal-title":"Mol Neurobiol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094654","article-title":"Histone methylation regulation in neurodegenerative disorders","volume":"22","author":"Basavarajappa BS","year":"2021","unstructured":"Basavarajappa BS, Subbanna S. Histone methylation regulation in neurodegenerative disorders. Int J Mol Sci. 2021, 22:4654. 10.3390\/ijms22094654","journal-title":"Int J Mol Sci"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2022.1123","article-title":"Sirtuins at the crossroads between mitochondrial quality control and neurodegenerative diseases: structure, regulation, modifications, and modulators","volume":"14","author":"Xu H","year":"2023","unstructured":"Xu H, Liu YY, Li LS, Liu YS. Sirtuins at the crossroads between mitochondrial quality control and neurodegenerative diseases: structure, regulation, modifications, and modulators. Aging Dis. 2023, 14:794-824. 10.14336\/AD.2022.1123","journal-title":"Aging Dis"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.660379","article-title":"microRNA dysregulation in Parkinson's disease: a narrative review","volume":"15","author":"Nies YH","year":"2021","unstructured":"Nies YH, Mohamad Najib NH, Lim WL, Kamaruzzaman MA, Yahaya MF, Teoh SL. microRNA dysregulation in Parkinson's disease: a narrative review. Front Neurosci. 2021, 15:660379. 10.3389\/fnins.2021.660379","journal-title":"Front Neurosci"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6952","article-title":"MicroRNA\u2011126 inhibits endothelial permeability and apoptosis in apolipoprotein E\u2011knockout mice fed a high\u2011fat diet","volume":"16","author":"Cheng XW","year":"2017","unstructured":"Cheng XW, Wan YF, Zhou Q, Wang Y, Zhu HQ. MicroRNA\u2011126 inhibits endothelial permeability and apoptosis in apolipoprotein E\u2011knockout mice fed a high\u2011fat diet. Mol Med Rep. 2017, 16:3061-8. 10.3892\/mmr.2017.6952","journal-title":"Mol Med Rep"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-020-00464-9","article-title":"Exploiting circulating microRNAs as biomarkers in psychiatric disorders","volume":"24","author":"Roy B","year":"2020","unstructured":"Roy B, Yoshino Y, Allen L, Prall K, Schell G, Dwivedi Y. Exploiting circulating microRNAs as biomarkers in psychiatric disorders. Mol Diagn Ther. 2020, 24:279-98. 10.1007\/s40291-020-00464-9","journal-title":"Mol Diagn Ther"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1080\/19491034.2024.2350180","article-title":"Long non-coding RNAs: roles in cellular stress responses and epigenetic mechanisms regulating chromatin","volume":"15","author":"Nickerson JA","year":"2024","unstructured":"Nickerson JA, Momen-Heravi F. Long non-coding RNAs: roles in cellular stress responses and epigenetic mechanisms regulating chromatin. Nucleus. 2024, 15:2350180. 10.1080\/19491034.2024.2350180","journal-title":"Nucleus"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073845","article-title":"Huntington's disease: complex pathogenesis and therapeutic strategies","volume":"25","author":"Tong H","year":"2024","unstructured":"Tong H, Yang T, Xu S, et al.. Huntington's disease: complex pathogenesis and therapeutic strategies. Int J Mol Sci. 2024, 25:3845. 10.3390\/ijms25073845","journal-title":"Int J Mol Sci"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2018.05.005","article-title":"Epigenetic regulation in neurodegenerative diseases","volume":"41","author":"Berson A","year":"2018","unstructured":"Berson A, Nativio R, Berger SL, Bonini NM. Epigenetic regulation in neurodegenerative diseases. Trends Neurosci. 2018, 41:587-98. 10.1016\/j.tins.2018.05.005","journal-title":"Trends Neurosci"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.117827","article-title":"The role of mitochondrial dysfunction in Huntington's disease: implications for therapeutic targeting","volume":"183","author":"Joshi DC","year":"2025","unstructured":"Joshi DC, Chavan MB, Gurow K, Gupta M, Dhaliwal JS, Ming LC. The role of mitochondrial dysfunction in Huntington's disease: implications for therapeutic targeting. Biomed Pharmacother. 2025, 183:117827. 10.1016\/j.biopha.2025.117827","journal-title":"Biomed Pharmacother"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-011-9375-5","article-title":"Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease","volume":"35","author":"Walker MP","year":"2013","unstructured":"Walker MP, LaFerla FM, Oddo SS, Brewer GJ. Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease. Age (Dordr). 2013, 35:519-31. 10.1007\/s11357-011-9375-5","journal-title":"Age (Dordr)"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00537","article-title":"Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation","volume":"11","author":"Shukla S","year":"2020","unstructured":"Shukla S, Tekwani BL. Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation. Front Pharmacol. 2020, 11:537. 10.3389\/fphar.2020.00537","journal-title":"Front Pharmacol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.03.011","article-title":"Molecular mechanisms directing PRC2 recruitment and H3K27 methylation","volume":"74","author":"Laugesen A","year":"2019","unstructured":"Laugesen A, H\u00f8jfeldt JW, Helin K. Molecular mechanisms directing PRC2 recruitment and H3K27 methylation. Mol Cell. 2019, 74:8-18. 10.1016\/j.molcel.2019.03.011","journal-title":"Mol Cell"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2025.1551107","article-title":"Chromatin modifiers in neurodevelopment","volume":"18","author":"Rezazadeh S","year":"2025","unstructured":"Rezazadeh S, Ji H, Giulivi C. Chromatin modifiers in neurodevelopment. Front Mol Neurosci. 2025, 18:1551107. 10.3389\/fnmol.2025.1551107","journal-title":"Front Mol Neurosci"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12090","article-title":"Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington's disease","volume":"124","author":"Soldati C","year":"2013","unstructured":"Soldati C, Bithell A, Johnston C, Wong KY, Stanton LW, Buckley NJ. Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington's disease. J Neurochem. 2013, 124:418-30. 10.1111\/jnc.12090","journal-title":"J Neurochem"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ibneur.2022.12.002","article-title":"The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders","volume":"14","author":"Rasmi Y","year":"2023","unstructured":"Rasmi Y, Shokati A, Hassan A, et al.. The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders. IBRO Neurosci Rep. 2023, 14:28-37. 10.1016\/j.ibneur.2022.12.002","journal-title":"IBRO Neurosci Rep"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00764","article-title":"The impact of one carbon metabolism on histone methylation","volume":"10","author":"Serefidou M","year":"2019","unstructured":"Serefidou M, Venkatasubramani AV, Imhof A. The impact of one carbon metabolism on histone methylation. Front Genet. 2019, 10:764. 10.3389\/fgene.2019.00764","journal-title":"Front Genet"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.110","article-title":"Epigenetic inheritance of disease and disease risk","volume":"38","author":"Bohacek J","year":"2013","unstructured":"Bohacek J, Mansuy IM. Epigenetic inheritance of disease and disease risk. Neuropsychopharmacology. 2013, 38:220-36. 10.1038\/npp.2012.110","journal-title":"Neuropsychopharmacology"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0460.1000420","article-title":"microRNAs in neurodegeneration: current findings and potential impacts","volume":"8","author":"Sharma S","year":"2018","unstructured":"Sharma S, Lu HC. microRNAs in neurodegeneration: current findings and potential impacts. J Alzheimers Dis Parkinsonism. 2018, 8:420. 10.4172\/2161-0460.1000420","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147686","article-title":"Dual role of microRNA-146a in experimental inflammation in human pulmonary epithelial and immune cells and expression in inflammatory lung diseases","volume":"25","author":"Gronau L","year":"2024","unstructured":"Gronau L, Duecker RP, Jerkic SP, et al.. Dual role of microRNA-146a in experimental inflammation in human pulmonary epithelial and immune cells and expression in inflammatory lung diseases. Int J Mol Sci. 2024, 25:7686. 10.3390\/ijms25147686","journal-title":"Int J Mol Sci"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01407-7","article-title":"Widespread alterations in microRNA biogenesis in human Huntington's disease putamen","volume":"10","author":"Petry S","year":"2022","unstructured":"Petry S, Keraudren R, Nateghi B, et al.. Widespread alterations in microRNA biogenesis in human Huntington's disease putamen. Acta Neuropathol Commun. 2022, 10:106. 10.1186\/s40478-022-01407-7","journal-title":"Acta Neuropathol Commun"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms141020427","article-title":"An emerging role for long non-coding RNA dysregulation in neurological disorders","volume":"14","author":"Fenoglio C","year":"2013","unstructured":"Fenoglio C, Ridolfi E, Galimberti D, Scarpini E. An emerging role for long non-coding RNA dysregulation in neurological disorders. Int J Mol Sci. 2013, 14:20427-42. 10.3390\/ijms141020427","journal-title":"Int J Mol Sci"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2019.104642","article-title":"Epigenetic mechanisms of neurodegenerative diseases and acute brain injury","volume":"133","author":"Bertogliat MJ","year":"2020","unstructured":"Bertogliat MJ, Morris-Blanco KC, Vemuganti R. Epigenetic mechanisms of neurodegenerative diseases and acute brain injury. Neurochem Int. 2020, 133:104642. 10.1016\/j.neuint.2019.104642","journal-title":"Neurochem Int"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2009.02.006","article-title":"Epigenetics, oxidative stress, and Alzheimer disease","volume":"46","author":"Zawia NH","year":"2009","unstructured":"Zawia NH, Lahiri DK, Cardozo-Pelaez F. Epigenetics, oxidative stress, and Alzheimer disease. Free Radic Biol Med. 2009, 46:1241-9. 10.1016\/j.freeradbiomed.2009.02.006","journal-title":"Free Radic Biol Med"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134718","article-title":"Epigenetics in Lewy body diseases: impact on gene expression, utility as a biomarker, and possibilities for therapy","volume":"21","author":"Urbizu A","year":"2020","unstructured":"Urbizu A, Beyer K. Epigenetics in Lewy body diseases: impact on gene expression, utility as a biomarker, and possibilities for therapy. Int J Mol Sci. 2020, 21:4718. 10.3390\/ijms21134718","journal-title":"Int J Mol Sci"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00082","article-title":"Cortical and striatal circuits in Huntington's disease","volume":"14","author":"Blumenstock S","year":"2020","unstructured":"Blumenstock S, Dudanova I. Cortical and striatal circuits in Huntington's disease. Front Neurosci. 2020, 14:82. 10.3389\/fnins.2020.00082","journal-title":"Front Neurosci"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111658","article-title":"Epigenetic explorations of neurological disorders, the identification methods, and therapeutic avenues","volume":"25","author":"Firdaus Z","year":"2024","unstructured":"Firdaus Z, Li X. Epigenetic explorations of neurological disorders, the identification methods, and therapeutic avenues. Int J Mol Sci. 2024, 25:11658. 10.3390\/ijms252111658","journal-title":"Int J Mol Sci"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-014-1656-6","article-title":"Histone deacetylase inhibitors and cell death","volume":"71","author":"Zhang J","year":"2014","unstructured":"Zhang J, Zhong Q. Histone deacetylase inhibitors and cell death. Cell Mol Life Sci. 2014, 71:3885-901. 10.1007\/s00018-014-1656-6","journal-title":"Cell Mol Life Sci"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2011-110080","article-title":"Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression","volume":"26","author":"Govindarajan N","year":"2011","unstructured":"Govindarajan N, Agis-Balboa RC, Walter J, Sananbenesi F, Fischer A. Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression. J Alzheimers Dis. 2011, 26:187-97. 10.3233\/JAD-2011-110080","journal-title":"J Alzheimers Dis"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.100982","article-title":"Lecanemab reduces brain amyloid-\u03b2 and delays cognitive worsening","volume":"4","author":"Knopman DS","year":"2023","unstructured":"Knopman DS. Lecanemab reduces brain amyloid-\u03b2 and delays cognitive worsening. Cell Rep Med. 2023, 4:100982. 10.1016\/j.xcrm.2023.100982","journal-title":"Cell Rep Med"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01915-3","article-title":"Alzheimer's disease and drug delivery across the blood-brain barrier: approaches and challenges","volume":"29","author":"Iqbal I","year":"2024","unstructured":"Iqbal I, Saqib F, Mubarak Z, et al.. Alzheimer's disease and drug delivery across the blood-brain barrier: approaches and challenges. Eur J Med Res. 2024, 29:313. 10.1186\/s40001-024-01915-3","journal-title":"Eur J Med Res"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01551-8","article-title":"Advances in targeting histone deacetylase for treatment of solid tumors","volume":"17","author":"Shi MQ","year":"2024","unstructured":"Shi MQ, Xu Y, Fu X, Pan DS, Lu XP, Xiao Y, Jiang YZ. Advances in targeting histone deacetylase for treatment of solid tumors. J Hematol Oncol. 2024, 17:37. 10.1186\/s13045-024-01551-8","journal-title":"J Hematol Oncol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1072651","article-title":"Recent progress in DNA methyltransferase inhibitors as anticancer agents","volume":"13","author":"Zhang Z","year":"2022","unstructured":"Zhang Z, Wang G, Li Y, et al.. Recent progress in DNA methyltransferase inhibitors as anticancer agents. Front Pharmacol. 2022, 13:1072651. 10.3389\/fphar.2022.1072651","journal-title":"Front Pharmacol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.3390\/nu13113979","article-title":"Targeting DNA methylation in the adult brain through diet","volume":"13","author":"Allison J","year":"2021","unstructured":"Allison J, Kaliszewska A, Uceda S, Reiriz M, Arias N. Targeting DNA methylation in the adult brain through diet. Nutrients. 2021, 13:3979. 10.3390\/nu13113979","journal-title":"Nutrients"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1534862","article-title":"Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases","volume":"15","author":"Hossam Abdelmonem B","year":"2025","unstructured":"Hossam Abdelmonem B, Kamal LT, Wardy LW, Ragheb M, Hanna MM, Elsharkawy M, Abdelnaser A. Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases. Front Oncol. 2025, 15:1534862. 10.3389\/fonc.2025.1534862","journal-title":"Front Oncol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00496-7","article-title":"The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives","volume":"16","author":"Walgrave H","year":"2021","unstructured":"Walgrave H, Zhou L, De Strooper B, Salta E. The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives. Mol Neurodegener. 2021, 16:76. 10.1186\/s13024-021-00496-7","journal-title":"Mol Neurodegener"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061252","article-title":"CRISPR-Cas9-based technology and its relevance to gene editing in Parkinson's disease","volume":"14","author":"Rahman MU","year":"2022","unstructured":"Rahman MU, Bilal M, Shah JA, Kaushik A, Teissedre PL, Kujawska M. CRISPR-Cas9-based technology and its relevance to gene editing in Parkinson's disease. Pharmaceutics. 2022, 14:1252. 10.3390\/pharmaceutics14061252","journal-title":"Pharmaceutics"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914865","article-title":"CRISPR\/dCas9 tools: Epigenetic mechanism and application in gene transcriptional regulation","volume":"24","author":"Cai R","year":"2023","unstructured":"Cai R, Lv R, Shi X, Yang G, Jin J. CRISPR\/dCas9 tools: Epigenetic mechanism and application in gene transcriptional regulation. Int J Mol Sci. 2023, 24:14865. 10.3390\/ijms241914865","journal-title":"Int J Mol Sci"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1177\/1460458218814893","article-title":"Current challenges in health information technology-related patient safety","volume":"26","author":"Sittig DF","year":"2020","unstructured":"Sittig DF, Wright A, Coiera E, Magrabi F, Ratwani R, Bates DW, Singh H. Current challenges in health information technology-related patient safety. Health Informatics J. 2020, 26:181-9. 10.1177\/1460458218814893","journal-title":"Health Informatics J"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02039-0","article-title":"Epigenetics-targeted drugs: current paradigms and future challenges","volume":"9","author":"Dai W","year":"2024","unstructured":"Dai W, Qiao X, Fang Y, et al.. Epigenetics-targeted drugs: current paradigms and future challenges. Signal Transduct Target Ther. 2024, 9:332. 10.1038\/s41392-024-02039-0","journal-title":"Signal Transduct Target Ther"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2014.03.008","article-title":"HDAC signaling in neuronal development and axon regeneration","volume":"27","author":"Cho Y","year":"2014","unstructured":"Cho Y, Cavalli V. HDAC signaling in neuronal development and axon regeneration. Curr Opin Neurobiol. 2014, 27:118-26. 10.1016\/j.conb.2014.03.008","journal-title":"Curr Opin Neurobiol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmac038","article-title":"Epigenetic effects of healthy foods and lifestyle habits from the southern European Atlantic diet pattern: a narrative review","volume":"13","author":"Lorenzo PM","year":"2022","unstructured":"Lorenzo PM, Izquierdo AG, Rodriguez-Carnero G, et al.. Epigenetic effects of healthy foods and lifestyle habits from the southern European Atlantic diet pattern: a narrative review. Adv Nutr. 2022, 13:1725-47. 10.1093\/advances\/nmac038","journal-title":"Adv Nutr"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.15092","article-title":"Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body \u03b2-hydroxybutyrate","volume":"5","author":"Sleiman SF","year":"2016","unstructured":"Sleiman SF, Henry J, Al-Haddad R, et al.. Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body \u03b2-hydroxybutyrate. Elife. 2016, 5:10.7554\/eLife.15092","journal-title":"Elife"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.07.033","article-title":"Excess translation of epigenetic regulators contributes to fragile X syndrome and is alleviated by BRD4 inhibition","volume":"170","author":"Korb E","year":"2017","unstructured":"Korb E, Herre M, Zucker-Scharff I, Gresack J, Allis CD, Darnell RB. Excess translation of epigenetic regulators contributes to fragile X syndrome and is alleviated by BRD4 inhibition. Cell. 2017, 170:1209-23.e20. 10.1016\/j.cell.2017.07.033","journal-title":"Cell"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10040861","article-title":"Early diagnostics and early intervention in neurodevelopmental disorders-age-dependent challenges and opportunities","volume":"10","author":"Hadders-Algra M","year":"2021","unstructured":"Hadders-Algra M. Early diagnostics and early intervention in neurodevelopmental disorders-age-dependent challenges and opportunities. J Clin Med. 2021, 10:861. 10.3390\/jcm10040861","journal-title":"J Clin Med"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2025.04.007","article-title":"Novel molecular biomarkers to guide treatment decision-making in metastatic urothelial cancer-a patient cohort analysis","author":"Robbrecht DG","year":"2025","unstructured":"Robbrecht DG, Salhi Y, Martens JW, et al.. Novel molecular biomarkers to guide treatment decision-making in metastatic urothelial cancer-a patient cohort analysis. Eur Urol Oncol. 2025, 10.1016\/j.euo.2025.04.007","journal-title":"Eur Urol Oncol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.10.012","article-title":"Decoding the epigenetic language of neuronal plasticity","volume":"60","author":"Borrelli E","year":"2008","unstructured":"Borrelli E, Nestler EJ, Allis CD, Sassone-Corsi P. Decoding the epigenetic language of neuronal plasticity. Neuron. 2008, 60:961-74. 10.1016\/j.neuron.2008.10.012","journal-title":"Neuron"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2016.0233","article-title":"Epigenetic changes in neurodegenerative diseases","volume":"39","author":"Kwon MJ","year":"2016","unstructured":"Kwon MJ, Kim S, Han MH, Lee SB. Epigenetic changes in neurodegenerative diseases. Mol Cells. 2016, 39:783-9. 10.14348\/molcells.2016.0233","journal-title":"Mol Cells"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.956839","article-title":"Epigenetic modifications: basic mechanisms and role in cardiovascular disease","volume":"123","author":"Handy DE","year":"2011","unstructured":"Handy DE, Castro R, Loscalzo J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation. 2011, 123:2145-56. 10.1161\/CIRCULATIONAHA.110.956839","journal-title":"Circulation"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-023-00598-6","article-title":"Interpreting non-coding disease-associated human variants using single-cell epigenomics","volume":"24","author":"Gaulton KJ","year":"2023","unstructured":"Gaulton KJ, Preissl S, Ren B. Interpreting non-coding disease-associated human variants using single-cell epigenomics. Nat Rev Genet. 2023, 24:516-34. 10.1038\/s41576-023-00598-6","journal-title":"Nat Rev Genet"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae352","article-title":"Transcriptomics and epigenetic data integration learning module on Google Cloud","volume":"25","author":"Ruprecht NA","year":"2024","unstructured":"Ruprecht NA, Kennedy JD, Bansal B, et al.. Transcriptomics and epigenetic data integration learning module on Google Cloud. Brief Bioinform. 2024, 25:bbae352. 10.1093\/bib\/bbae352","journal-title":"Brief Bioinform"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113425","article-title":"The impact of nutrition and environmental epigenetics on human health and disease","volume":"19","author":"Tiffon C","year":"2018","unstructured":"Tiffon C. The impact of nutrition and environmental epigenetics on human health and disease. Int J Mol Sci. 2018, 19:3425. 10.3390\/ijms19113425","journal-title":"Int J Mol Sci"},{"key":"ref104","article-title":"A comprehensive study on epigenetic biomarkers in early detection and prognosis of Alzheimer's disease","volume":"1","author":"Parikh D","year":"2024","unstructured":"Parikh D, Shah M. A comprehensive study on epigenetic biomarkers in early detection and prognosis of Alzheimer's disease. Biomed Anal. 2024, 1:138-53.","journal-title":"Biomed Anal"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-63233-3.00005-1","article-title":"Epigenetic mechanisms underlying nervous system diseases","volume":"147","author":"Qureshi IA","year":"2018","unstructured":"Qureshi IA, Mehler MF. Epigenetic mechanisms underlying nervous system diseases. Handb Clin Neurol. 2018, 147:43-58. 10.1016\/B978-0-444-63233-3.00005-1","journal-title":"Handb Clin Neurol"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112092","article-title":"Elucidating neuroepigenetic mechanisms to inform targeted therapeutics for brain disorders","volume":"28","author":"Weekley BH","year":"2025","unstructured":"Weekley BH, Ahmed NI, Maze I. Elucidating neuroepigenetic mechanisms to inform targeted therapeutics for brain disorders. iScience. 2025, 28:112092. 10.1016\/j.isci.2025.112092","journal-title":"iScience"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-021-00324-2","article-title":"Machine learning in pain medicine: an up-to-date systematic review","volume":"10","author":"Matsangidou M","year":"2021","unstructured":"Matsangidou M, Liampas A, Pittara M, Pattichi CS, Zis P. Machine learning in pain medicine: an up-to-date systematic review. Pain Ther. 2021, 10:1067-84. 10.1007\/s40122-021-00324-2","journal-title":"Pain Ther"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-024-00584-8","article-title":"Incorporation of \"artificial intelligence\" for objective pain assessment: a comprehensive review","volume":"13","author":"El-Tallawy SN","year":"2024","unstructured":"El-Tallawy SN, Pergolizzi JV, Vasiliu-Feltes I, et al.. Incorporation of \"artificial intelligence\" for objective pain assessment: a comprehensive review. Pain Ther. 2024, 13:293-317. 10.1007\/s40122-024-00584-8","journal-title":"Pain Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/397318-epigenetic-dysregulation-in-neurodegenerative-disease-implications-for-neuropathology-and-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:09:57Z","timestamp":1755302997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/397318-epigenetic-dysregulation-in-neurodegenerative-disease-implications-for-neuropathology-and-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":108,"URL":"https:\/\/doi.org\/10.7759\/cureus.90188","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,15]]}}}